LENSAR, INC. Net Change in Cash
LENSAR, INC. (LNSR) reported Net Change in Cash of $591.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-13
- LENSAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$480.00K, a 114.62% decline year-over-year.
- LENSAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $3.28M.
- LENSAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$6.66M.
- LENSAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$6.70M.
- LENSAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$3.29M.
- LENSAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$4.36M, a 173.28% decline from fiscal 2023.
- LENSAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $5.95M.
- LENSAR, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$16.96M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $591.00K 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | -$480.00K 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | -$3.29M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$8.63M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$9.11M 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | $3.28M 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | -$4.36M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | -$10.18M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$12.33M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$6.66M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $5.95M 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $10.25M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | $10.79M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$6.70M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$16.96M 10-K · filed 2024-03-04 | |||
| 2022-09-30 | -$12.34M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$6.44M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$2.65M 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$8.96M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | -$8.26M 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | -$6.04M 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | -$4.73M 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $35.88M 10-K · filed 2022-03-03 | |||
| 2020-09-30 | $37.99M 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | -$2.07M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $1.27M 10-K · filed 2021-03-12 | |||
| 2019-09-30 | -$2.08M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |